Environmental contributions to the allergic asthma epidemic. by Kheradmand, Farrah et al.
Environmental Health Perspectives • VOLUME 110 | SUPPLEMENT 4 | AUGUST 2002 553
Evidence has accumulated over the past 30
years indicating that the allergic syndromes,
especially asthma, have increased in prevalence
and severity (1). These trends have, for perhaps
the ﬁrst time, transformed what was formerly a
relatively inconspicuous ailment into an epi-
demic illness of signiﬁcant public health con-
cern. In addition to chronic disability and
negative impact on quality of life, the eco-
nomic burden of asthma is now substantial
(2,3). Perhaps most disturbing, these alarming
asthma statistics are not confined to the
United States but are reﬂected throughout the
industrialized world (4), creating an unprece-
dented medical conundrum. Legitimate doubt
as to the existence of the asthma epidemic may
be raised on the basis of supporting epidemio-
logic data. Many studies documenting a rise in
disease prevalence are based on patient ques-
tionnaires, which are subject to considerable
bias. Despite this and other methodologic
objections, an increase in asthma prevalence
has been consistently documented throughout
the world—indeed, there appear to be no
studies that refute this trend (4). Further,
asthma mortality data, which provide a far
more objective end point than prevalence sta-
tistics, are also increasing in the same countries
where prevalence is rising (5). Thus, despite
reasonable objections to the methodology of
many supporting studies, current literature
overwhelmingly supports the existence of a
true asthma epidemic.
In this review we consider the potential role
the environment in mediating the epidemic of
asthma. We ﬁrst consider the immune mecha-
nisms that may underlie the causes of asthma
and subsequently the major theories that have
recently emerged to explain the epidemic. 
The Immune Response 
and Asthma
Many of the asthma epidemic theories incor-
porate recent insights into the immunopatho-
logic basis of allergic inflammation.
Inﬂammatory responses are complex, involving
numerous cells and secreted products that acti-
vate a diverse range of host-protective
responses. However, partially compensating
for this complexity is the redundancy of
immune responses, in which the same inﬂam-
matory mechanisms are activated in response
to many different inﬂammatory insults. This
redundancy is such that much of immunity
can be organized into two principal responses
called T-helper type 1 (TH1) and type 2
(TH2). TH1 cells, which secrete interferon
gamma and other cytokines, confer protection
against pathogens such as bacteria. In contrast,
TH2 cells, which secrete cytokines such as
interleukin (IL) 4, IL-5, and IL-13, control
larger pathogens such as parasitic worms. Both
T-cell types are mutually antagonistic and are
rarely found together at the same inﬂamma-
tory site. T-helper cells are usually protective,
of course, but they are also associated with
maladaptive responses. TH2 cells especially are
thought to contribute to allergic diseases
including asthma and allergic rhinitis (6,7) by
secreting cytokines such as IL-4 and IL-13 (8)
or by promoting secretion of allergenic
products such as immunoglobulin E (IgE) (9). 
Theories of the Asthma
Epidemic
The major theories regarding the asthma
epidemic propose that environmental changes
create a relative imbalance in TH1 and TH2
cells and/or an overall increase in allergenic
products. Yet, despite what appears to be a uni-
fying pathophysiologic framework, extremely
diverse theories have emerged. Under the fol-
lowing subheadings, we discuss the evidence
that supports and refutes these theories and
indicate where future studies might be helpful
in clarifying unresolved issues.
Infection
Through complex means, a variety of infec-
tions are believed to inﬂuence the expression
of asthma. For example, a relative deﬁciency
in TH1-inducing infections or inﬂammations
involving the upper and lower airway may
lead to excess TH2 activation in the airway
(10,11). Presumably, low-grade infections
with TH1-dependent pathogens such as
Mycobacterium tuberculosis, the causative agent
of human tuberculosis, and related organisms
antagonize TH2 cells and thereby suppress dis-
eases such as asthma. Experimental support
for this theory exists, as shown by the ability
of mycobacteria such as M. tuberculosis to sup-
press allergic lung inflammation (12,13). In
addition, certain bacterial products such as
DNA (unmethylated CpG motifs) are suffi-
cient to block or reverse experimental allergic
lung disease (14). However, the negative sta-
tistical association of tuberculin reactivity
(a skin test–based index of exposure to
M. tuberculosis) with subsequent atopic disease
in Japanese schoolchildren (10) has not been
conﬁrmed in other populations (15). Further,
although mycobacterial diseases such as tuber-
culosis have been declining in importance for
a century or more (16), it is not clear why this
has resulted in increased allergic disease only
in the last 30 years. Thus, while mycobacteria
and their products clearly antagonize allergic
lung inﬂammation, the evidence that exposure
to these organisms has changed sufﬁciently to
account for the epidemic is inconclusive. 
Other infections are proposed to
contribute to allergic disease, including chronic
infections with the bacterium Chlamydia pneu-
moniae, respiratory viruses, parasites such as
Toxocara canis, and fungi, including Aspergillus
species. In all respects, these organisms differ
markedly from each other and probably con-
tribute in very different ways to allergic disease.
Parasites and fungi likely cause disease directly,
as extracts from these organisms are powerful
allergens (17,18). Despite their long associa-
tions with asthma, the mechanisms by which
C. pneumoniae and viruses may mediate aller-
gic disease are not clear. However, in an
allergic setting, an inappropriate TH2
immune response may be generated against
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clearance of the infection and effectively con-
verting the organism into a self-replicating
allergen (19). In accord with a recent study,
eradication of the organism under these cir-
cumstances may not necessarily resolve the
underlying asthma (20). Thus, some infections
may exacerbate existing disease, but no studies
yet demonstrate that infections are intrinsic
causes of asthma, and they cannot currently be
implicated in the asthma epidemic.
A related theory proposes an entirely
different etiology for allergic disease—that
lack of TH2-dependent pathogens, especially
intestinal helminths, creates an imbalance of
polyclonal compared with speciﬁc IgE. Lack
of exposure to parasites is proposed to lead to
increased specific IgE, which, if not coun-
tered by the effects of polyclonal antibody,
becomes extremely efficient at triggering
allergic disease (21). Parasite infestations
have clearly declined in Western societies,
but like tuberculosis, this trend was all but
complete long before the asthma epidemic
began. Further, additional data suggest that
asthma rates may not differ significantly
between urban, parasite-free groups and
rural, heavily parasitized populations, sug-
gesting that factors other than parasites
themselves may be more important (22).
Another serious obstacle with this hypothesis
is the clinical evidence that elimination of
virtually all IgE, using modiﬁed neutralizing
antibodies, has little effect on clinically rele-
vant physiologic end points in asthma
patients (23). 
The Hygiene Hypothesis
This theory also implicates a variety of infec-
tions or microbial products (or lack thereof)
in mediating immune bias in favor of TH2
reactivity and predisposition to asthma. An
important additional tenet of this theory is
that such exaggerated TH2 conditioning
occurs primarily in the perinatal period,
involving the aberrant tendency of the
neonate to preferentially mount TH2 immu-
nity. With maturity, the immune system
adopts a more balanced activation profile
characterized by both TH1 and TH2
responses (24). For unclear reasons, geneti-
cally predisposed individuals retain their
TH2 predisposition, potentially resulting in
childhood asthma that carries over into
adulthood (25). A critical assumption of this
theory is that maternally acquired allergens
are carried across the placenta and against
which the fetus begins making TH2
responses (26). Thus, the fetus is literally
born allergic. Genetic factors are acknowl-
edged to play a role, but these are presum-
ably secondary to primary alterations in
exposure to the various infectious agents or
their products discussed earlier. In addition,
hyperactive intrauterine mechanisms that
attempt to limit the embryotoxic effects of
TH1 cytokines are also thought to play a role
(25).
In addition to the difficulties in under-
standing how infections may contribute to
the asthma epidemic, several independent
observations challenge the assumption that
the neonatal immune response is TH2 biased
and therefore predisposed to asthma. The
greater susceptibility of neonates to infec-
tions, rather than indicative of such an
abnormality, more likely reflects simply a
normal one that has yet to develop memory.
Further, whereas some innate components of
immunity such as neutrophils may be truly
immature or only partially functional in the
neonate (27), neonatal T cells actually pro-
duce both TH1 and TH2 cytokines compara-
ble to their adult counterparts (28). Also,
rather than inducing ineffective immune
responses, as some reports have implied,
immunization of newborns or even fetal
baboons with common antigens produces
normal, competent antibody responses (29).
Thus, there are few data to support the exis-
tence of an intrinsic, neonatal T-cell defect
that might underlie a predisposition to
allergy. It is further difficult to understand
how antigens would accumulate in the
maternal blood in sufﬁcient quantity to cross
over to the fetus to induce sensitization.
Neonatal T cells do react to a variety of food-
borne and other environmental antigens, but
this appears to be an extremely common and
perhaps ubiquitous feature of pregnancy, and
therefore one that is unlikely to participate in
the asthma epidemic (30,31). However,
other mechanisms by which the neonate
might acquire an allergic predisposition have
been suggested. One provocative concept is
that maternal-derived amniotic cytokines
bias the developing fetal immune system
toward TH2 reactivity (32). 
The maternal–fetal relationship is
clearly complex and one that may have
important consequences for allergic reactiv-
ity and asthma in early and late life.
Maternal intrauterine factors may ulti-
mately be shown to be important in deter-
mining allergic reactivity of the newborn,
but it is unclear how such mechanisms can
account for the asthma epidemic. It seems
more likely at this time that an environ-
mental factor simultaneously affecting the
mother and the newborn may largely
account for concomitant maternal and
neonatal allergic sensitization and asthma,
and perhaps the asthma epidemic as well. 
Air Pollution
Certain air pollutants are associated with
respiratory allergy and have been shown
experimentally to modify TH2 function and
IgE secretion. Tobacco smoke acts as an
immunologic adjuvant, promoting antigen-
specific IgE production in sensitized mice
(33). More general air pollutants may also
influence the severity of allergic disease.
Diesel exhaust particles (DEP) augment
nasal cytokine production and increase pro-
duction of allergen-specific IgE in humans
(34,35). In mice, DEP exacerbate antigen-
induced experimental allergic airway disease
but are incapable of inducing disease inde-
pendent of antigen (36). Therefore, like
certain infectious etiologies, diverse hydro-
carbon-based air pollutants may exacerbate
existing allergic disease, but there is no evi-
dence yet that they give rise to new cases,
and their role in the asthma epidemic con-
sequently remains to be established.
Aspirin Use
The use of aspirin in pediatric patients
began to decline about 20 years ago at
approximately the time when the childhood
asthma epidemic began. Aspirin, unlike its
substitute acetaminophen, blocks prosta-
glandin E2 (PGE2) synthesis by inhibiting
the enzyme cyclooxygenase-2. PGE2 in turn
promotes TH2 development and TH2-like
effects. The switch away from aspirin to
acetaminophen in children, the result of
aspirin’s association with the devastating
neurologic illness Reye’s syndrome, there-
fore, resulted in a population with higher
average PGE2 levels and potentially greater
susceptibility to allergic diseases such as
asthma (37). Arguing against this provoca-
tive theory is that the asthma epidemic also
involves adults who use aspirin. Further,
other cyclooxygenase inhibitors, including
nonsteroidal anti-inflammatory drugs such
as ibuprofen, are commonly used in children
and do not induce Reye’s syndrome. Finally,
no independent association of aceta-
minophen use with the asthma epidemic in
children has yet been determined.
Exercise and Obesity
This theory postulates that decreased physical
activity and increased obesity, increasingly
common characteristics of American children,
might partly be responsible for the epidemic
(38). These same changes are associated with
epidemic increases in other lifestyle-related
illnesses such as type 2 diabetes mellitus, sug-
gesting a possible common etiology between
childhood asthma and diabetes (39).
Although intriguing, no studies have yet pro-
vided insight into how asthma might arise
with decreased activity, obesity, or diabetes.
However, the evolving lifestyle of the
Westernized child probably also includes
greater amounts of time spent indoors, per-
haps resulting in increased exposure to an
indoor pollutant that induces asthma.
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There exists a consistent biochemical
connection between the allergens associated
with asthma and other organisms that activate
TH2 cells and allergic mechanisms. The larvae
of intestinal parasites secrete many products,
but of particular interest are proteases, which
they require presumably to burrow through
host connective tissue that otherwise impedes
their visceral migrations (40). As secreted
products common to virtually all intestinal
helminths, proteases are therefore logical trig-
gers for immune, and especially TH2, activa-
tion and parasite eradication. Other
organisms associated with allergic reactivity
and asthma also possess protease activity. The
pollen of many plant species contains pro-
teases required for fertilization. Because they
cannot take food internally, fungi, which are
strongly associated with asthmalike diseases
such as allergic bronchopulmonary aspergillo-
sis (41), must secrete proteases to digest
organic matter. Further, the house dust mite,
the organism serologically most commonly
linked with asthma, is thought to shed a vari-
ety of asthmagenic proteins, but the most
important of these are also proteases (42).
Finally, the major cat allergen identiﬁed from
the serum of asthma patients, Fel d I, is, or is
associated with, a protease (43). 
The strong association of proteases and
clinically relevant allergens suggests a testable
hypothesis regarding the role of these
enzymes in asthma. This theory predicts that
proteases act as immunologic adjuvants or
costimulatory molecules, directing TH2 acti-
vation without necessarily serving as antigens
themselves. Such a nonimmunogenic, adju-
vant role of proteases would be required to
explain the lack of serologically identifiable
protease in other major human allergens.
Even if shown, a TH2 adjuvant role for pro-
teases does not by itself explain the asthma
epidemic. Among other tasks, a change in
overall accumulation and exposure to envi-
ronmental proteases would have to be docu-
mented around the time at which the
epidemic began. Surprisingly, such potential
sources were originally identiﬁed many years
ago and include laundry detergent proteases
that proved to be risk factors for asthma in
detergent factory workers (44,45). It is also
striking that the ﬁrst documentation of these
epidemics occurred immediately before the
global asthma epidemic, at a time when
worldwide distribution of enzyme-containing
cleaning products was just beginning. What
remains unclear, however, is whether indus-
trially derived proteases have accumulated
worldwide within the populations experienc-
ing the asthma epidemic. Mechanistic insight
into how proteases activate TH2 cells is also
lacking, although recent studies have begun
to address this issue. For example, proteases
may facilitate antigen presentation through
the airway by disrupting airway tight junc-
tions (46) and may exacerbate existing disease
by disrupting IgE receptors (42).
Conclusions
A summary of the major theories deployed
recently to account for the asthma epidemic,
including the major arguments supporting
and refuting them, is presented in Table 1.
What most clearly emerges from this sum-
mary is a lack of experimental evidence that
strongly supports any of the proposed
hypotheses. Several environmental perturba-
tions have the potential to modify immune
function, particularly regarding TH2 activa-
tion, in ways that may exacerbate preexisting
asthma. Thus, the adjuvant-like effects of air
pollution–based hydrocarbons and the relative
lack of PGE2 due to decreased aspirin use may
similarly increase production of IgE and TH2
cytokines, thereby aggravating preexisting
asthma. However, such agonist effects on
disease are undocumented for any actual pop-
ulation of asthmatics. The other mechanisms
are less clearly associated with immune func-
tion but are intriguing, primarily because of
their statistical/epidemiologic associations
with asthma and/or the asthma epidemic. The
several epidemiologic links between environ-
mental proteases and asthma are particularly
interesting, but available data only weakly link
proteases to immune function. Maternal–fetal
interactions that may influence neonatal
immune function also have intriguing connec-
tions to allergic disease, but the hygiene
hypothesis is significantly undermined by
conﬂicting data. Finally, environmental per-
turbations must be shown to induce new cases
of disease before they can account for the
asthma epidemic. Strikingly, none of the pro-
posed mechanisms has yet been shown to be
etiologic in this most important regard.
Future studies on the causes of the
asthma epidemic will require new experi-
mental and epidemiologic approaches and
the expertise of diverse scientists. The results
of these investigations are difficult to pre-
dict. None of the current epidemic theories
can be dismissed on the basis of available
data, but it is unlikely that all will be found
to have merit after further study. A likely
outcome of future research is that a more
inclusive epidemic theory will emerge, one
that incorporates features of some of the
current hypotheses as well as wholly new
concepts. A multifactorial etiology of the
epidemic appears likely at this time, but a
single major environmental factor, perhaps
one of those considered above, may ulti-
mately be shown to be most important.
Future investigations will be valued not
merely as academic exercises but as a means
for resolving the asthma epidemic and
improving respiratory health worldwide.
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Table 1. Theories of the asthma epidemic.
Theory Arguments for Arguments against
Infection Decline in TH1-inducing infections facilitates TH2 activation  Conﬂicting epidemiologic data; lack of supporting experimental data
Respiratory tract pathogens directly activate TH2 cells Lack of supporting experimental data
Decline in helminth infestations results in more antigen-speciﬁc IgE Recent data do not support a major role for IgE in asthma; conﬂicting 
association of parasites with asthma
Hygiene Decline in TH1-inducing microbial products worldwide  Epidemiologic data are conﬂicting; lack of supporting experimental data
leads to excess TH2 activation Conﬂicting data about the true predisposition of the neonatal immune system
Neonates intrinsically predisposed to TH2 responses
Air pollution Hydrocarbons in air pollution can act as TH2 adjuvants and  Air pollution has declined during the asthma epidemic; lack of evidence that
trigger asthma hydrocarbons actually cause allergic disease
Aspirin Aspirin use among children has declined during the asthma epidemic  The asthma epidemic also involves adults who use aspirin; children take
Aspirin use negatively linked to TH2 development by blocking  other cyclooxygenase inhibitors 
cyclooxygenase products that favor TH2 development  No epidemic associations with noncyclooxygenase-blocking aspirin substitutes
(acetaminophen)
Diet/exercise Decreased exercise, obesity, and diabetes are statistically  Experimental data supporting these associations are lacking
associated with symptoms of asthma
Protease Protease activity a consistent feature of many allergens Not all allergens contain serologically deﬁned proteases
Proteases linked to occupational asthma Mechanistic insight lacking
Environmental sources of protease have increased during the No documentation of a true rise in environmental proteases
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